Men and women were excluded from the study if they had:
• Urinary incontinence caused by any other condition (e.g. bladder
stones or bladder surgery).
• More than 200 mL of urine left in the bladder after urination
(before starting the treatment).
• A urinary tract infection.
• Received botulinum toxin.
• Received medicines directly into the bladder through a catheter.
A total of 21 patients received the study medicine. The table below shows the gender
and age of these patients.
Patients who received the study medicine
Placebo Botulinum toxin type A
10 patients 11 patients
Gender – number of patients (percent)
Female 1 (10%) 3 (27%)
Male 9 (90%) 8 (73%)
Age - in years
Range 21 to 81 21 to 63
Average 47 51
For more detailed information about the patients included in this study, see the
scientific results summary (a link to the summary is provided at the end of this
document).